FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

713311003: Glycine max oil refined (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3288890015 Soya bean oil refined en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3311812012 Soybean oil refined en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4023731014 Soy bean oil refined en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4023734018 Soya oil refined en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5069489016 Glycine max oil refined (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
5069490013 Glycine max oil refined en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
32061000188118 huile de soja raffinée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Soya bean oil refined Is a Soya bean oil true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1
Product containing only Glycine max oil refined in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Soya bean oil refined Inferred relationship Some 1
Product containing Glycine max oil refined (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Soya bean oil refined Inferred relationship Some 1
Product containing only Glycine max oil refined (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Soya bean oil refined Inferred relationship Some 1
Product containing Glycine max oil refined in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 100 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Soya bean oil refined Inferred relationship Some 1
Product containing precisely Glycine max oil refined 200 milligram/1 milliliter conventional release emulsion for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Soya bean oil refined Inferred relationship Some 1

This concept is not in any reference sets

Back to Start